Differential expression of diacylglycerol kinase ζ is involved in inferior parietal lobule-related dysfunction in schizophrenia with cognitive impairments

Author:

Liu Xiao-Fan1,Zhao Shu-Wan2,Cui Jin-Jin3,Gu Yue-Wen2,Fan Jing-Wen2,Fu Yu-Fei2,Zhang Ya-Hong4,Yin Hong1,Chen Kun2,Cui Long-Biao2

Affiliation:

1. Shaanxi University of Chinese Medicine

2. Air Force Medical University

3. Chinese PLA General Hospital

4. Xijing Hospital

Abstract

Abstract Background: Cognitive impairment is the main factor in poor prognosis of schizophrenia, but its mechanism remains unclear. The inferior parietal lobule (IPL) is related to various clinical symptoms and cognitive impairment in schizophrenia. We aimed to explore the relationship between IPL-related functions and cognitive impairment in schizophrenia. Methods: 136 schizophrenia patients and 146 demographically matched healthy controls were enrolled. High-spatial-resolution structural images and resting-state functional images were acquired to demonstrate the alternations of brain structure and function, while the digit span and digit symbol task of the Chinese Wechsler Adult Intelligence Test Revised (WAIS-RC) were utilized in assessing the cognitive function of the subjects. Based on the Allen Human Brain Atlas, we obtained genes that were differentially expressed in the left IPL and then intersected with the results of transcriptome-wide association study results. Results: We found a negative correlation between digit span backward task score and amplitude of low-frequency fluctuation (ALFF) of the left IPL in healthy controls (r= −0.388, P = 0.003), which was not seen in patients (r = 0.203, P = 0.020). In addition, none of the other correlation analyses wasstatistically significant (P > 0.017). In addition, We found that diacylglycerol kinase ζ (DGKζ) is differentially expressed in the left IPL and associated with schizophrenia. Conclusion: Our study demonstrates the left IPL plays a vital role in cognitive impairment in schizophrenia. DGKζ may act as an essential regulator in the left IPL of schizophrenia patients with cognitive impairment.

Publisher

Research Square Platform LLC

Reference32 articles.

1. 1. Roberts NLS, Mountjoy-Venning WC, Anjomshoa M, Banoub JAM, Yasin YJ. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study (vol 392, pg 1789, 2018). The Lancet. 2019; 393:E44.

2. 2. Huang Y. Prevalence of mental disorders in China - Author's reply. Lancet Psychiatry. 2019; 6:468.

3. 3. Mucci A, Galderisi S, Gibertoni D, Rossi A, Rocca P, Bertolino A, Aguglia E, Amore M, Bellomo A, Biondi M et al. Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses. JAMA Psychiatry. 2021; 78:550–559.

4. 4. McCutcheon RA, Reis Marques T, Howes OD. Schizophrenia-An Overview. JAMA Psychiatry. 2020; 77:201–210.

5. 5. Goff DC. The Pharmacologic Treatment of Schizophrenia-2021. JAMA. 2021; 325:175–176.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3